Aclaris Therapeutics (ACRS) EBITDA (2014 - 2026)
Aclaris Therapeutics (ACRS) reported EBITDA of -$24.13 million for Q2 2026, compared with -$18.29 million a year earlier.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) EBITDA (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Aclaris Therapeutics' EBITDA came in at -$85.89 million; for FY2025, it was -$75.92 million.
- By year, EBITDA came in at -$141.13 million in FY2024, -$96.49 million in FY2023, -$89.06 million in FY2022 and -$88.8 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly EBITDA since Q4 2024.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$22.09 million (Q1 2026), -$22.63 million (Q4 2025) and -$17.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Aclaris Therapeutics | 638.89 Mn | 236.88 Mn | 1.29 Mn | -21.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -21.24 Mn |
| Jun 30, 2026 | -24.13 Mn |
| Mar 31, 2026 | -22.09 Mn |
| Dec 31, 2025 | -22.63 Mn |
| Sep 30, 2025 | -17.04 Mn |
| Jun 30, 2025 | -18.29 Mn |
| Mar 31, 2025 | -17.96 Mn |
| Dec 31, 2024 | -99.53 Mn |
| Sep 30, 2024 | -10.29 Mn |
| Jun 30, 2024 | -12.61 Mn |
| Mar 31, 2024 | -18.69 Mn |
| Dec 31, 2023 | -3.82 Mn |
| Sep 30, 2023 | -31.36 Mn |
| Jun 30, 2023 | -31.60 Mn |
| Mar 31, 2023 | -29.72 Mn |
| Dec 31, 2022 | -28.89 Mn |
| Sep 30, 2022 | -20.68 Mn |
| Jun 30, 2022 | -20.79 Mn |
| Mar 31, 2022 | -18.70 Mn |
| Dec 31, 2021 | -22.70 Mn |
API Access
Aclaris Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();